MedPath
NMPA Approval

Remifentanil Hydrochloride for Injection

国药准字H20123421

July 28, 2022

国药准字H20123421

Drug Information

注射用盐酸瑞芬太尼

注射剂

2mg(按C₂₀H₂₈N₂O₅计)

化学药品

July 28, 2022

Company Information

Applicant Company

廊坊经济技术开发区创业路

Manufacturing Company

廊坊经济技术开发区创业路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.